Founded By Pioneers In Biopharmaceuticalsrenova Therapeutics Is Developing A Portfolio Of Definitive Gene And Peptide Therapies To Restore Health To People Suffering From Cardiovascular And Metabolic Diseases Our Investigational Therapies Are Based On Carefully Validated And Proprietary Research Into Disease Mechanisms And The Foundersnearly 50 Combined Years Of Work In The Gene Therapy Fieldthis Experience Enables Us To Generate An Entirely Original Platform Of Therapeutics And Delivery Systems That In A Single Dose Are Designed To Provide Durablelife Long Treatments For Chronic Diseases Our Scientific Researchled By Drhkirk Hammondappears Ina Numerous Peer Reviewed Articles That Establish The Scientific Rationale And Evidence Supporting The Development Of Our Pipeline And Our Novel Approach To Delivering Gene Therapies The First Indications The Company Is Pursuing Are Gene Therapy Treatments For Congestive Heart Failurechfand Type 2 Diabetestwo Of The Most Common And Devastating Chronic Diseases In The Worldthe Company S Lead Productrt 100Is A Treatment That Delivers A Therapeutic Gene Directly To The Heart During A Routine Outpatient Procedure And Has The Potential To Increase Heart Function In Millions Of Patients With Chfthe Renova Therapeutics Pipeline Also Includes A Groundbreaking Gene Therapy In Preclinical Stage For Sufferers Of Type 2 Diabetesas Well As A Peptide Infusion Therapy For The Treatment Of Acute Decompensated Heart Failure Our Missioncreating Transformational Gene And Peptide Therapies That Treat The Most Prevalent Diseases To Restore Health And Renew Lifeour Visiona Future In Which We Are Able To Permanently Treat Chronic Diseases With Gene And Peptide Therapies
